cis-3-(4-(Trifluoromethyl)phenyl)cyclobutanamine

Catalog No. :
ACUDXJ850
CAS No. :
1812174-93-8
Molecular Formula :
C11H12F3N
Molecular Weight :
215.22

IUPAC Name:(1s,3s)-3-(4-(trifluoromethyl)phenyl)cyclobutan-1-amine

cis-3-(4-(Trifluoromethyl)phenyl)cyclobutanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$491.00Login to see priceIn stockInquiry
250mg95%$784.00Login to see priceIn stockInquiry
500mg95%$1307.00Login to see priceInquiryInquiry
1g95%$1959.00Login to see priceInquiryInquiry
5g95%$5876.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-3-(4-(Trifluoromethyl)phenyl)cyclobutanamine
IUPAC Name(1s,3s)-3-(4-(trifluoromethyl)phenyl)cyclobutan-1-amine
MDL No.MFCD30471257
Molecular FormulaC11H12F3N
Molecular Weight215.22
SMILESN[C@H]1C[C@@H](C2=CC=C(C(F)(F)F)C=C2)C1
InChI KeyZUSHQSYFWIQVNY-WAAGHKOSSA-N
Synonym1812174-93-8 | cis-3-[4-(trifluoromethyl)phenyl]cyclobutanamine | cis-3-(4-(Trifluoromethyl)phenyl)cyclobutanamine | 3-[4-(trifluoromethyl)phenyl]cyclobutan-1-amine | 1808069-04-6 | trans-3-(4-(Trifluoromethyl)phenyl)cyclobutanamine | TRANS-3-(4-TRIFLUORO
CAS No.1812174-93-8
PubChem CID50988668

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACUDXJ850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUDXJ850 route product structure diagram
    ACUDXJ8501812174-93-8 In Stock
Inquiry

2. ACUDXJ850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUDXJ850 route product structure diagram
    ACUDXJ8501812174-93-8 In Stock
Inquiry

Comments (0)